NasdaqCM - Delayed Quote USD

Mangoceuticals, Inc. (MGRX)

2.0300
+0.0200
+(1.00%)
At close: June 13 at 4:00:01 PM EDT
1.9800
-0.05
(-2.46%)
After hours: June 13 at 7:44:19 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for MGRX

Recent News: MGRX

View More
Mangoceuticals shares results from field studies on MGX-0024

Mangoceuticals shares results from field studies on MGX-0024
TipRanks 17 days ago
Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu
GlobeNewswire 18 days ago
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division
GlobeNewswire last month
Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions
ACCESS Newswire last month
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape
ACCESS Newswire last month
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada
GlobeNewswire 2 months ago
Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments

Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments
GlobeNewswire 3 months ago
Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution
GlobeNewswire 3 months ago
Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research

Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research
GlobeNewswire 4 months ago
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation
GlobeNewswire 4 months ago
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
GlobeNewswire 5 months ago
View More

Related Tickers

ZCMD Zhongchao Inc.
1.1500
-12.88%
 
ESSI Eco Science Solutions, Inc.
0.0236
-30.12%
 
2587.HK HEALTHYWAY INC
55.050
+9.55%
 
FOXO FOXO Technologies Inc.
0.2161
-11.03%
 
VSEE VSee Health, Inc.
1.0100
-9.42%
 
NARA.CN Pangenomic Health Inc.
0.8100
+6.58%
 
ICCT iCoreConnect Inc.
0.2540
-15.33%
 
SLP Simulations Plus, Inc.
19.07
-4.89%
 
ACON Aclarion, Inc.
7.44
-0.79%
 
OTRK Ontrak, Inc.
1.4300
-2.05%